Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

New Crypto: Pepeto Announces $10.96M Raised While Ethereum Price Prediction Climbs to $40,000

September 12, 2026

New accessible playground opens in Saskatoon

September 11, 2026

Stellantis signs MOU on Brampton, Ont., plant as talks with union break down

September 11, 2026

Dawson community marks 20 years since college shooting

September 11, 2026

Lethbridge firefighters honoured at annual memorial: ‘What we signed up to do’

September 11, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Host Todd Vande Hei and Dr. Alice Nguyen Explore Cardiovascular Impacts of Plaquex on Health Is a Skill
Press Release

Host Todd Vande Hei and Dr. Alice Nguyen Explore Cardiovascular Impacts of Plaquex on Health Is a Skill

By News RoomJanuary 21, 20263 Mins Read
Host Todd Vande Hei and Dr. Alice Nguyen Explore Cardiovascular Impacts of Plaquex on Health Is a Skill
Share
Facebook Twitter LinkedIn Pinterest Email

Beverly Hills California, Jan. 21, 2026 (GLOBE NEWSWIRE) — Dr. Alice Nguyen, a licensed naturopathic doctor, joined host Todd Vande Hei on the Health Is a Skill podcast to provide a scientific deep dive into phosphatidylcholine IV therapy—commonly known as Plaquex—and its role in cardiovascular and neurological health. The discussion centered on cell membrane repair, endothelium support, and how these mechanisms may influence outcomes in conditions like high blood pressure, stroke recovery, and lipid imbalance.

The episode highlighted Nguyen’s clinical experience with Plaquex and its potential as an adjunctive treatment alongside conventional pharmaceuticals and lifestyle changes. Vande Hei shared his personal case: after increasing Plaquex IV frequency post-stroke, his long-standing blood pressure normalized within six weeks.

“Phosphatidylcholine is a key structural component of the cell membrane,” said Nguyen. “When we restore membrane integrity, especially in vascular endothelial cells, we often observe improvements in blood vessel function and inflammatory response.”

Nguyen also outlined the nutritional roots of choline, found in foods like liver and runny egg yolks, and discussed the challenges of obtaining therapeutic levels from diet or oral supplements alone. She emphasized that while Plaquex infusions can be powerful, they are most effective when combined with optimized lifestyle factors including body composition, sleep, hormone balance, and toxin reduction.

The conversation addressed broader cardiovascular topics such as the omega-3 to omega-6 ratio, heavy metal exposure (e.g., mercury from environmental sources), and the limitations of relying solely on statins or lipid panels. Nguyen noted that advanced imaging, including Coronary Computed Tomography Angiography (CCTA) paired with AI tools like Cleerly, offers a more nuanced picture of plaque development and regression.

“What’s fascinating is the case data we’re gathering,” said Nguyen. “In patients who refuse pharmaceuticals but commit to Plaquex, targeted supplementation, and lifestyle interventions, we’re beginning to see measurable improvements in vessel health and blood pressure.”

Key Takeaways from This Episode:

  • Plaquex (phosphatidylcholine IV) supports cell membrane and endothelium health
  • IV therapy differs significantly from oral choline supplements
  • Neurological benefits include post-stroke inflammation control and acetylcholine production
  • Nutritional choline sources include liver and runny egg yolks
  • Environmental toxins and omega imbalance contribute to cardiovascular damage
  • Case studies suggest Plaquex may aid in normalizing blood pressure
  • Best outcomes occur when combined with lifestyle and pharmaceutical strategies

About Health Is a Skill Podcast
Health Is a Skill is hosted by Todd Vande Hei, CEO of Stark, and focuses on redefining health as a lifelong pursuit of intentional habits. Each episode features conversations with industry leaders and experts across wellness, performance, and personal development.

Media Communications:

[email protected]

  • Todd Vande Hei and Dr. Alice Nguyen on Health Is a Skill

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

New Crypto: Pepeto Announces $10.96M Raised While Ethereum Price Prediction Climbs to $40,000

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

The GLP-1 Boom Is Bypassing Latino Patients; Bilingual Telehealth Clinic Sol y Vida Launches to Change That

California Waste Solutions Approaches 35 Years of Recycling and Global Environmental Infrastructure

“BEYOND THE EXTREME" Digital Music Night Debuts at ICEBAR Stockholm

SALOMON AND IRONMAN ANNOUNCE LONG-TERM PARTNERSHIP, TAKING ENDURANCE WHERE IT GOES NEXT

Erica Zarkovich, Chief Market and Partnerships Officer, Named One of Canada’s Most Powerful Women: Top 100

HII is Awarded Long-Lead Time Materials Contract for CVN 82

Crypto News Today: MemeToro Leaves Solana and XRP Behind as Presale Moves Toward Stage 7 Sellout

Editors Picks

New accessible playground opens in Saskatoon

September 11, 2026

Stellantis signs MOU on Brampton, Ont., plant as talks with union break down

September 11, 2026

Dawson community marks 20 years since college shooting

September 11, 2026

Lethbridge firefighters honoured at annual memorial: ‘What we signed up to do’

September 11, 2026

Latest News

Mark Carney meets with ‘Forever Canadian’ campaigners in Banff

September 11, 2026

Ikea supersized its cheap Bluetooth speaker and added an optical input

September 11, 2026

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

September 11, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version